Table 4.

Multivariate Bayesian analysis for survival using the Weibull proportional hazards model (n = 351)


Variable

Coefficient

Standard error

Hazard ratio (95% CI)
Constant   -10.760   NA   NA  
t(4;14)(p16;q32)*  0.574   0.179   1.78 (1.23-2.50)  
t(14;16)(q32;q23)*  0.513   0.286   1.67 (0.92-2.83)  
Deletion 17p13*  0.291   0.188   1.34 (0.92-1.93)  
▵13*  0.244   0.119   1.28 (1.01-1.61)  
t(11;14)(q13;q32)*  -0.213   0.163   0.81 (0.58-1.11)  
Creatinine, 2 or more vs less than 2 mg/dL  0.580   0.165   1.79 (1.29-2.44)  
PC labeling index, 1% or higher vs less than 1%   0.441   0.123   1.55 (1.22-1.97)  
C-reactive protein, 2 or more vs less than 2 mg/dL   0.435   0.175   1.54 (1.09-2.16)  
Bone marrow involvement, 30% or higher vs less than 30%
 
0.354
 
0.116
 
1.43 (1.14-1.79)
 

Variable

Coefficient

Standard error

Hazard ratio (95% CI)
Constant   -10.760   NA   NA  
t(4;14)(p16;q32)*  0.574   0.179   1.78 (1.23-2.50)  
t(14;16)(q32;q23)*  0.513   0.286   1.67 (0.92-2.83)  
Deletion 17p13*  0.291   0.188   1.34 (0.92-1.93)  
▵13*  0.244   0.119   1.28 (1.01-1.61)  
t(11;14)(q13;q32)*  -0.213   0.163   0.81 (0.58-1.11)  
Creatinine, 2 or more vs less than 2 mg/dL  0.580   0.165   1.79 (1.29-2.44)  
PC labeling index, 1% or higher vs less than 1%   0.441   0.123   1.55 (1.22-1.97)  
C-reactive protein, 2 or more vs less than 2 mg/dL   0.435   0.175   1.54 (1.09-2.16)  
Bone marrow involvement, 30% or higher vs less than 30%
 
0.354
 
0.116
 
1.43 (1.14-1.79)
 

NA indicates not applicable.

*

Present versus absent.

Convert creatinine to SI units: multiply mg/dL × 76.25 = μM.

or Create an Account

Close Modal
Close Modal